BlackRock Fund Advisors - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 31 filers reported holding CYTOSORBENTS CORP in Q2 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2016$351,000
+2.0%
64,489
+19.9%
0.00%
Q3 2016$344,000
+40.4%
53,807
-0.2%
0.00%
Q2 2016$245,000
+61.2%
53,915
+39.3%
0.00%
Q1 2016$152,000
-34.5%
38,712
-6.9%
0.00%
Q4 2015$232,000
-7.6%
41,596
+4.5%
0.00%
Q3 2015$251,0000.0%39,795
-2.6%
0.00%
Q2 2015$251,00040,8450.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Skylands Capital, LLC 1,772,000$13,379,0001.58%
Sargent Investment Group, LLC 856,315$6,465,0001.53%
Avenir Corp 1,366,549$10,317,0000.82%
CM Management, LLC 150,000$1,133,0000.82%
Winning Points Advisors, LLC 136,900$1,035,0000.78%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,397,0000.46%
SECTORAL ASSET MANAGEMENT INC 244,660$1,847,0000.15%
Redmile Group, LLC 1,304,369$9,848,0000.15%
Granahan Investment Management 1,003,546$7,577,0000.14%
ACT CAPITAL MANAGEMENT, LLC 35,000$265,0000.14%
View complete list of CYTOSORBENTS CORP shareholders